Janus Henderson Group PLC trimmed its position in shares of Envista Holdings Corporation (NYSE:NVST – Free Report) by 11.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 421,915 shares of the company’s stock after selling 53,900 shares during the quarter. Janus Henderson Group PLC’s holdings in Envista were worth $10,705,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd grew its stake in shares of Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after acquiring an additional 1,504 shares during the period. Allworth Financial LP lifted its position in shares of Envista by 75.4% in the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock worth $39,000 after buying an additional 776 shares in the last quarter. UMB Bank n.a. boosted its position in shares of Envista by 46.1% during the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock valued at $44,000 after acquiring an additional 636 shares during the last quarter. IFP Advisors Inc grew its stake in shares of Envista by 102.9% in the 4th quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock worth $46,000 after buying an additional 1,071 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Envista by 73.1% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after acquiring an additional 949 shares during the last quarter.
Envista Stock Performance
NYSE NVST opened at $27.94 on Wednesday. Envista Holdings Corporation has a twelve month low of $18.77 and a twelve month high of $30.42. The stock has a market cap of $4.55 billion, a PE ratio of 68.15, a P/E/G ratio of 1.55 and a beta of 0.86. The stock has a fifty day simple moving average of $25.76 and a 200-day simple moving average of $25.96. The company has a current ratio of 2.44, a quick ratio of 2.06 and a debt-to-equity ratio of 0.47.
Analyst Ratings Changes
Several brokerages have recently weighed in on NVST. Morgan Stanley increased their price target on Envista from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, April 24th. Piper Sandler upped their target price on Envista from $25.00 to $26.00 and gave the stock a “neutral” rating in a report on Wednesday, July 29th. JPMorgan Chase & Co. lifted their price objective on shares of Envista from $26.00 to $29.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Wall Street Zen lowered Envista from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. Finally, BMO Capital Markets assumed coverage on shares of Envista in a report on Wednesday, July 8th. They issued a “market perform” rating and a $27.00 price target for the company. Six research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat.com, Envista has a consensus rating of “Hold” and an average price target of $28.62.
Check Out Our Latest Stock Analysis on NVST
Envista Profile
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Read More
- Five stocks we like better than Envista
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
